[CIS PIDD] [cis-pidd] STAT1 GOF treatment options

Daniel Conway dhconway at hotmail.com
Sat Sep 20 12:45:40 EDT 2014


If systemic steroids were successful, one may consider triamcinolone dental paste.  

Sincerely,
Daniel H. Conway, MD
Assistant Professor of Pediatrics
St. Christopher's Hospital for Children
Drexel University College of Medicine

> On Sep 20, 2014, at 11:51 AM, "Laham, Federico R." <Federico.Laham at orlandohealth.com> wrote:
> 
> Dear Elena,
> 
> I saw a 7 year old girl with suspected STAT1 GOF mutation, her father has a confirmed diagnosis. She broke into these same aphthous ulcers you described after receiving amoxicillin for a ear infection.  Her father say the same thing would happen to him. They cannot take penicillin as the reaction is nearly predictable. Mouth cultures were also negative for herpes. Orajel or magic mouth washes provided very little relief.  Curiously she did not experience significant issues with fungal infections, but common infections appear to last longer.
> 
> Her father stated that the ulcers would also present sporadically, but he 'learnt to live with them'.
> 
> Best wishes,
> 
> Federico Laham, MD
> Arnold Palmer Hospital for Children
> Orlando, Florida
> 
>> On Sep 19, 2014, at 7:01 PM, Elena Hsieh <whsieh at stanford.edu> wrote:
>> 
>> Hi there,
>> 
>> We have a 16yo girl with STAT1 gain of function mutation, with CMC, oral cavity and esophagus in the past.  Her main issue is that she has recurrent episodes of painful oral ulcers and sores.  She also has trouble and pain swallowing, to the point where she gets admitted for IV hydration and pain management with opiate PCA.  Culture from these lesions do not often grow candida, but her esophageal scope demonstrated positivity for candida stains.
>> 
>> She has been treated with multiple antifungals, including fluconazole, voriconazole, now IV caspofungin for this current episode.
>> 
>> As far as immunosupression, given these lesions do not always seem to be fungal, she has been treated with methotrexate and plaquenil in the past without much benefit.  She does respond to systemic steroids sometimes, but is not a good long term plan.  We just recently started her on GMCSF based on the JACI report from 2013, but we had tried that in the past without much benefit either.
>> 
>> Any additional suggestions?
>> 
>> Thanks.
>> 
>> Elena Hsieh, MD
>> Allergy and Immunology
>> Instructor
>> Stanford University
>> 
>> ---
>> The CIS-PIDD listserv is supported by the Clinical Immunology Society
>> The science & practice of human immunology
>> 
>> P: +1.414.224.8095
>> E: info at clinimmsoc.org
>> 
>> Not a member of CIS? Please visit www.clinimmsoc.org to join!
>> 
>> You are currently subscribed to cis-pidd as: federico.laham at orlandohealth.com.
>> To unsubscribe click here: http://lm.clinimmsoc.org/u?id=206575721.018fe44dc0cb5d7e58c94eaf8b5a522a&n=T&l=cis-pidd&o=45513485
>> or send a blank email to leave-45513485-206575721.018fe44dc0cb5d7e58c94eaf8b5a522a at lists.clinimmsoc.org
> 
> ________________________________
> 
> This e-mail message and any attached files are confidential and are intended solely for the use of the addressee(s) named above. If you are not the intended recipient, any review, use, or distribution of this e-mail message and any attached files is strictly prohibited.
> 
> This communication may contain material protected by Federal privacy regulations, attorney-client work product, or other privileges. If you have received this confidential communication in error, please notify the sender immediately by reply e-mail message and permanently delete the original message. To reply to our email administrator directly, send an email to: postmaster at orlandohealth.com .
> 
> If this e-mail message concerns a contract matter, be advised that no employee or agent is authorized to conclude any binding agreement on behalf of Orlando Health by e-mail without express written confirmation by an officer of the corporation. Any views or opinions presented in this e-mail are solely those of the author and do not necessarily represent those of Orlando Health.
> 
> ---
> The CIS-PIDD listserv is supported by the Clinical Immunology Society
> The science & practice of human immunology
> 
> P: +1.414.224.8095
> E: info at clinimmsoc.org
> 
> Not a member of CIS? Please visit www.clinimmsoc.org to join!
> 
> You are currently subscribed to cis-pidd as: dhconway at hotmail.com.
> To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824436.ff92e3b04ea7d4047458ee3ec0fc8f24&n=T&l=cis-pidd&o=45516009
> or send a blank email to leave-45516009-183824436.ff92e3b04ea7d4047458ee3ec0fc8f24 at lists.clinimmsoc.org

---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org to join!

You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=45516185
or send a blank email to leave-45516185-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org


More information about the PAGID mailing list